Icecure Medical Ltd [NASDAQ: ICCM] price plunged by -2.63 percent to reach at -$0.03.
A sum of 15217666 shares traded at recent session while its average daily volume was at 1.78M shares. Icecure Medical Ltd shares reached a high of $1.4 and dropped to a low of $0.9261 until finishing in the latest session at $0.96.
The one-year ICCM stock forecast points to a potential upside of 62.93. The average equity rating for ICCM stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Icecure Medical Ltd [ICCM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ICCM shares is $2.59 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ICCM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 19.95, with the Price to Cash per share for the same quarter was set at 0.08.
ICCM Stock Performance Analysis:
Icecure Medical Ltd [ICCM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.49. With this latest performance, ICCM shares dropped by -9.06% in over the last four-week period, additionally sinking by -20.12% over the last 6 months – not to mention a drop of -10.69% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ICCM stock in for the last two-week period is set at 42.38, with the RSI for the last a single of trading hit 0.0902, and the three-weeks RSI is set at 0.0756 for Icecure Medical Ltd [ICCM]. The present Moving Average for the last 50 days of trading for this stock 0.9831, while it was recorded at 0.9943 for the last single week of trading, and 1.1177 for the last 200 days.
Insight into Icecure Medical Ltd Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Icecure Medical Ltd [ICCM] shares currently have an operating margin of -569.07% and a Gross Margin at 35.92%. Icecure Medical Ltd’s Net Margin is presently recorded at -559.02%.
Icecure Medical Ltd (ICCM) Capital Structure & Debt Analysis
According to recent financial data for Icecure Medical Ltd. ( ICCM), the Return on Equity (ROE) stands at -230.80%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -120.09%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Icecure Medical Ltd’s Return on Invested Capital (ROIC) is -528.14%, showcasing its effectiveness in deploying capital for earnings.
Icecure Medical Ltd (ICCM) Efficiency & Liquidity Metrics
Based on Icecure Medical Ltd’s (ICCM) latest financial statements, the Debt-to-Equity Ratio is 0.82%, indicating its reliance on debt financing relative to shareholder equity.
Icecure Medical Ltd (ICCM) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Icecure Medical Ltd. (ICCM) effectively leverages its workforce, generating an average of -$216388.89 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.18% and a Quick Ratio of 0.88%, indicating strong ability to cover short-term liabilities.
ICCM Stock EPS
With the latest financial reports released by the company, Icecure Medical Ltd posted -0.08/share EPS, while the average EPS was predicted by analysts to be reported at -0.08/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ICCM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Icecure Medical Ltd go to 31.41%.
Icecure Medical Ltd [ICCM] Institutonal Ownership Details
There are presently around $0.36%, or 0.61%% of ICCM stock, in the hands of institutional investors. The top three institutional holders of ICCM stocks are: CITADEL ADVISORS LLC with ownership of 0.17 million shares, which is approximately 0.3627%. RENAISSANCE TECHNOLOGIES LLC, holding 66400.0 shares of the stock with an approximate value of $$49136.0 in ICCM stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $$20000.0 in ICCM stock with ownership which is approximately 0.0582%.
